农业百科

Enifer’s commercial-scale biomass fermentation facility in Kantvik, Finland, should become operational in the second hal…

Bristol Myers Squibb (BMS) will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology, and immunology, the companies said today, through a collaboration that could generate more than $15.2 billion for the Chinese drug developer.

Researchers at Jiangnan University have engineered microbial “cell factories” to sustainably produce the UV-protective compound gadusol, a compound that could eventually serve as a sunscreen ingredient and an antioxidant additive.

在巴斯夫工作12年后，罗德里戈·布尔奇·迪亚斯（如图）已加入住友化学拉丁美洲公司，担任战略销售规划经理一职。他将常驻戈亚斯州戈亚尼亚市。

Antibiotic resistance is on the rise around the world, creating an urgent need for faster and more dependable approaches to design antimicrobial candidates. While AI-driven methods have accelerated antimicrobial discovery, most have focused on screening fixed libraries or generating broad candidate sets.

面对农业生产中自然资源的日益枯竭，新的模式应运而生，旨在利用自然生态系统机制而非完全依赖化学投入。花卉种植——即在作物内部或周围种植花带或花坛——便是促进生物多样性并同时提高产量的替代方案之一。这些措施不仅仅是装饰，它们还有助于植被和土壤的恢复，并强化授粉和生物防治等重要的生态系统服务。

AI is only as powerful as the data from which it learns. How can researchers provide enough high-quality input data to fuel this engine and design next-generation precision medicine? [Herstockart/Getty Images]

化肥市场持续承压，中东地缘政治紧张局势以及生产和物流成本上涨支撑了价格。根据伊塔乌BBA农业咨询公司（Itaú BBA’s Agro Consulting）发布的《农业月报——五月报告》（Agro Mensal – Maio），氮肥和磷肥价格持续高企，而巴西的需求则因生产商谨慎补充库存而放缓。

Cellares, an Integrated Development and Manufacturing Organization (IDMO) that combines  automated manufacturing platforms with global Smart Factory infrastructure , and ProTgen, a therapeutic company pioneering targeted Notch activators to reactivate the thymus and reconstitute the adaptive immune system, have announced a partnership to automate manufacturing and quality control of ProT-096, ProTgen’s personalized progenitor T-cell therapy for patients with refractory leukemia and other hematologic malignancies. In this collaboration, Cellares will apply the company’s Cell Shuttle and Cell Q platforms to ProT-096 while providing regulatory support toward IND submission.